Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor-related protein agonist AMG 228 in patients with advanced solid tumors (Q58698379)
Jump to navigation
Jump to search
scholarly article by Ben Tran et al published 25 September 2018 in Journal for Immunotherapy of Cancer
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor-related protein agonist AMG 228 in patients with advanced solid tumors |
scholarly article by Ben Tran et al published 25 September 2018 in Journal for Immunotherapy of Cancer |
Statements
Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor-related protein agonist AMG 228 in patients with advanced solid tumors (English)
0 references
25 September 2018
0 references
6
0 references
1
0 references
93
0 references
25 September 2018
1 reference